LB Pharmaceuticals Raises $100 Million in Private Placement with Shares and Pre-Funded Warrants Issued
I'm PortAI, I can summarize articles.
LB Pharmaceuticals Inc. has raised $100 million through a private placement, issuing pre-funded warrants for 1,417,107 shares and 3,306,571 shares of common stock to institutional investors. Each pre-funded warrant is priced at $21.1699, which is the common stock price minus a nominal exercise fee. The funds will support a Phase 2 trial for LB-102, aimed at treating major depressive disorder, and for general corporate purposes.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments